ACHFF (Arch Biopartners) Beginning Cash Position : $0.22 Mil (As of Mar. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Arch Biopartners Beginning Cash Position?

Arch Biopartners's Beginning Cash Position for the quarter that ended in Mar. 2024 was $0.22 Mil.

Arch Biopartners's quarterly Beginning Cash Position declined from Sep. 2023 ($1.03 Mil) to Dec. 2023 ($0.62 Mil) and declined from Dec. 2023 ($0.62 Mil) to Mar. 2024 ($0.22 Mil).

Arch Biopartners's annual Beginning Cash Position declined from Sep. 2021 ($0.52 Mil) to Sep. 2022 ($0.34 Mil) but then increased from Sep. 2022 ($0.34 Mil) to Sep. 2023 ($0.37 Mil).

Arch Biopartners Beginning Cash Position Historical Data

The historical data trend for Arch Biopartners's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arch Biopartners Beginning Cash Position Chart

Arch Biopartners Annual Data

Trend

Sep14

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Beginning Cash Position

Get a 7-Day Free Trial

0.41

0.30

0.52

0.34

0.37

Arch Biopartners Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Beginning Cash Position	Get a 7-Day Free Trial															0.12	0.53	1.03	0.62	0.22

Arch Biopartners Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

Arch Biopartners Beginning Cash Position Related Terms

Thank you for viewing the detailed overview of Arch Biopartners's Beginning Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Arch Biopartners Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arch Biopartners Inc (OTCPK:ACHFF) » Definitions » Beginning Cash Position

Comparable Companies

Traded in Other Exchanges

ARCH:Canada

Address

545 King Street West, Toronto, ON, CAN, M5V 1M1

Website

https://www.archbiopartners.com

Arch Biopartners Inc is a clinical stage company developing technologies with the potential to make medical or commercial impacts. The company is developing a drug platform Metablok to produce drug candidates to inhibit organ inflammation caused via the DPEP-1 pathway. It's under development portfolio is AB569, a potential new treatment for antibiotic resistant bacterial infections in the lungs or wounds; and, Borg peptide coatings that increase corrosion resistance and decrease bacterial biofilm on various medical grade metals and plastics.